Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in vietnamese patients

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Tong, Hoang V ^a   Toan, Nguyen L ^b   Song, Le H ^c   Ouf, Eman Abou ^a   Bock, C Thomas ^d,e   Kremsner, Peter G ^a   Kun, Jürgen F J ^a   TP, Velavan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^c Tran Hung Dao Hospital   (Viet Nam)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FICOLIN; FICOLIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ETHNIC GROUP; FCN2 GENE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; INTRON; LIVER CELL CARCINOMA; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIETNAMESE; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LECTINS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VIETNAM; VIRAL LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 81555207977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028113     Document Type: Article

References (32)

1. Lavanchy D, (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
2. Nguyen VT, Law MG, Dore GJ, (2008) An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int 28: 525-531.
3. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595.
4. Song IH, Toan NL, Xuan NT, Uhlemann AC, Boldt AB, et al. (2006) A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B. Mutat Res 601: 137-143.
5. Song IH, Xuan NT, Toan NL, Binh VQ, Boldt AB, et al. (2008) Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection. Eur Cytokine Netw 19: 204-210.
6. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, et al. (2008) Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet 35: 255-264.
7. Song IH, Binh VQ, Duy DN, Juliger S, Bock TC, et al. (2003) Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. Mutat Res 522: 119-125.
8. Hummelshoj T, Thielens NM, Madsen HO, Arlaud GJ, Sim RB, et al. (2007) Molecular organization of human Ficolin-2. Mol Immunol 44: 401-411.
9. Endo Y, Matsushita M, Fujita T, (2007) Role of ficolin in innate immunity and its molecular basis. Immunobiology 212: 371-379.
10. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, et al. (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 14: 1651-1658.
11. Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P, (2008) Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol 45: 2508-2520.
12. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, et al. (2007) The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 65: 383-392.
13. Atkinson AP, Cedzynski M, Szemraj J, St Swierzko A, Bak-Romaniszyn L, et al. (2004) L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 138: 517-520.
14. Chapman SJ, Vannberg FO, Khor CC, Segal S, Moore CE, et al. (2007) Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Mol Immunol 44: 3267-3270.
15. Ruskamp JM, Hoekstra MO, Postma DS, Kerkhof M, Bottema RW, et al. (2009) Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clin Exp Immunol 155: 433-440.
16. Faik I, Oyedeji SI, Idris Z, Messias-Reason IJ, Lell B, et al. (2011) Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol 72: 74-79.
17. Messias-Reason I, Kremsner PG, Kun JF, (2009) Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199: 801-804.
18. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF, (2009) Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 157: 395-399.
19. Liu J, Ali MA, Shi Y, Zhao Y, Luo F, et al. (2009) Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 6: 235-244.
20. Toan NL, Song IH, Kremsner PG, Duy DN, Binh VQ, et al. (2006) Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 43: 1375-1384.
21. He YL, Zhao YR, Zhang SL, Lin SM, (2006) Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 12: 4788-4793.
22. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
23. Kilpatrick DC, Fujita T, Matsushita M, (1999) P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol Lett 67: 109-112.
24. Le Y, Lee SH, Kon OL, Lu J, (1998) Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett 425: 367-370.
25. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, et al. (2007) Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 44: 856-865.
26. Lee WM, (1997) Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
27. Gao B, Jeong WI, Tian Z, (2008) Liver: An organ with predominant innate immunity. Hepatology 47: 729-736.
28. Racanelli V, Rehermann B, (2006) The liver as an immunological organ. Hepatology 43: S54-S62.
29. Qin X, Gao B, (2006) The complement system in liver diseases. Cell Mol Immunol 3: 333-340.
30. Wieland S, Thimme R, Purcell RH, Chisari FV, (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674.
31. Chong WP, To YF, Ip WK, Yuen MF, Poon TP, et al. (2005) Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 42: 1037-1045.
32. Thio CL, Mosbruger T, Astemborski J, Greer S, Kirk GD, et al. (2005) Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol 79: 9192-9196.